Drugmaker Endo cuts full-year sales forecast, shares slide

(Reuters) - Endo International Plc on Tuesday lowered its full-year revenue forecast, saying it expected lower sales of branded drugs to add to the pricing pressure its generic drugs are facing, sending the company's shares to their lowest since 2003.